NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023

Area of Science:

• Urology
• Oncology
• Medical Guidelines

Background:

• Prostate cancer early detection programs aim to identify clinically significant disease.
• Informed decision-making requires understanding the benefits and drawbacks of screening.

Purpose of the Study:

• To summarize recent updates to the NCCN Guidelines for Prostate Cancer Early Detection.
• To optimize the detection of clinically significant prostate cancer.
• To minimize the detection of indolent prostate cancer.

Main Methods:

• Review of recent updates to the NCCN Guidelines.
• Focus on testing protocols, multiparametric MRI (mpMRI), and negative biopsy management.

Main Results:

• Revised recommendations for prostate cancer screening protocols.
• Inclusion of multiparametric MRI in the diagnostic pathway.
• Updated strategies for managing patients with negative biopsy results.

Conclusions:

• The updated NCCN guidelines aim to enhance the accuracy of early prostate cancer detection.
• These revisions support better differentiation between aggressive and indolent forms of the disease.
• Optimized protocols assist clinicians in managing prostate cancer screening effectively.